Search

everythinglearnresearchcommunity

for

Search:↓

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a viable alternative.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

The case shows the importance of quick and thorough evaluation of adrenal tumors to prevent rapid disease progression and poor outcomes.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

GLPLS and LPP are variants of lichen planus.

Light therapy successfully treated a dog's hair growth problem without side effects.

Low-level laser therapy speeds up skin healing and stimulates hair follicles in mice after radiation exposure.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

Upadacitinib may effectively treat resistant lichen planopilaris.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

Combining medication and minimally invasive techniques can effectively manage Marine-Lenhart syndrome.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Human scalp fat stem cells showed improved cartilage-like development on a special scaffold with freeze-thaw treatment.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

Early diagnosis of leprosy is crucial to prevent disabilities and spread, even in non-endemic areas.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

L-Carnitine-L-tartrate may help hair grow and prevent hair loss.

Lifestyle factors like BMI at young adulthood can increase cancer risk in women with Lynch Syndrome, but diet and height don't seem to affect this risk.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.